Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19

Author
Demirkol, Mustafa Asim
Esatoglu, Sinem Nihal
Altunok, Elif Sargin
Cengel, Ferhat
Gurkan, Okan
Satici, Celal
Metadata
Show full item record
Abstract
Purpose: There is scarce data on the impact of the presence of mediastinal lymphadenopathy on the prognosis of coronavirus-disease 2019 (COVID-19). We aimed to investigate whether its presence is associated with increased risk for 30-day mortality in a large group of patients with COVID-19.
URI
http://hdl.handle.net/20.500.12627/175703
https://doi.org/10.1016/j.clinimag.2021.01.028
Collections